Avelumab in Refractory Testicular Germ Cell Cancer.

Clinical trial NCT03403777 · COMPLETED

Trial details

NCT number: NCT03403777
Sponsor: National Cancer Institute, Slovakia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Testicular Neoplasms Neoplasms, Germ Cell and Embryonal Neoplasms Testicular Diseases Gonadal Disorders Antineoplastic Agents Molecular Mechanisms of Pharmacological Action

Start date: 2017-11-15
Primary completion: 2019-02-28
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.